LSE:VEC (Vectura Group)

About vec

Vectura develops inhaled therapies principally for the treatment of respiratory diseases.

Vectura Group (LSE: VEC)
Latest News

Investing Articles

Why I see 50% upside in this pharmaceutical firm in 2017

Bilaal Mohamed explains why this pharamceutical firm could have massive growth potential over the coming year.

Read more »

Investing Articles

Will Vectura Group plc outperform AstraZeneca plc after today’s results gain a Brexit boost?

Is Vectura Group plc (LON: VEC) a more attractive buy than healthcare peer AstraZeneca plc (LON: AZN)?

Read more »

Investing Articles

Could Vectura Group plc grow to be a FTSE 100 company within 10 years?

Vectura Group plc (LON:VEC) could follow in the footsteps of Hikma Pharmaceuticals (LON:HIK), says G A Chester.

Read more »

Investing Articles

2 pharmaceutical shares that could make you a fortune

Bilaal Mohamed uncovers two pharmaceutical firms with the potential to deliver substantial shareholder returns.

Read more »

Investing Articles

Why Vectura group plc and GlaxoSmithKline plc could be the perfect combination

GlaxoSmithKline plc (LON: GSK) and Vectura Group plc (LON: VEC) have many complementary qualities.

Read more »

Investing Articles

Should You Ditch GlaxoSmithKline plc And Buy Vectura Group PLC And SkyePharma PLC?

Are these 2 pharmaceutical stocks better buys that GlaxoSmithKline plc (LON: GSK)? Check out Vectura Group PLC (LON: VEC) and…

Read more »

Investing Articles

Are Vectura Group PLC, AstraZeneca plc And Lookers PLC ‘Screaming Buys’?

Should you add these 3 stocks to your portfolio? Vectura Group PLC (LON: VEC), AstraZeneca plc (LON: AZN) and Lookers…

Read more »

Investing Articles

Are Vectura Group PLC And Circassia Pharmaceuticals PLC Better Buys Than GlaxoSmithKline plc?

Should you add Vectura Group PLC (LON: VEC) and Circassia Pharmaceuticals PLC (LON: CIR) to your portfolio before GlaxoSmithKline plc…

Read more »